Your search returned 54 results .

Cervical Cancer

City of Hope is a nationally recognized leader in the research and treatment of cervical cancer. Our treatments include minimally invasive surgery, individually customized chemotherapy regimens and highly precise radiation delivery.

Gynecologic Cancers

City of Hope is a nationally recognized leader in the research and treatment of gynecologic cancers and U.S. News & World Report has named us one of the top cancer and gynecological hospitals in America.

City of Hope Women's Center

The Women’s Center has moved to a new location at City of Hope’s Duarte campus. For our patients, this means greater convenience and comfort in a modern facility with a serene atmosphere. They will also receive a more coordinated care experience.

Stephen J. Lee, M.D.

Clinical Specialties : Gynecologic Oncology

Areas of Expertise : Cervical Cancer,Heated Intraperitoneal Chemotherapy (HIPEC),Ovarian Cancer,Uterine (Endometrial) Cancer,Robotic Surgery

Amy Hakim, M.D., M.S.

Clinical Specialties : Gynecologic Oncology

Areas of Expertise : Gynecologic Oncology Surgery

Thanh H. Dellinger, M.D.

Clinical Specialties : Gynecologic Oncology

Research Focus : Uterine/Endometrial cancer, Novel therapies in Ovarian cancer, Hyperthermic intraperitoneal cancer, Peer counseling and Quality of Life in Cancer Patients

Mark Wakabayashi, M.D., M.P.H.

Clinical Specialties : Gynecologic Oncology

Research Focus : Gynecologic Oncology

Ashley Baker Lee

Ashley Baker Lee is Senior Vice President of Research Operations at City of Hope, overseeing clinical and basic research operations and providing administrative leadership for Beckman Research Institute.

Cervical cancer: Much progress, still too many diagnoses

Cervical cancer was once one of the most-common causes of cancer death for women in the United States. Now, with better screening techniques, targeted treatments and vaccinations, the death rate has declined dramatically.

Bottom line on cervical cancer screenings: More testing needed

Questions swirl around recommendations for various cancer screenings these days, and now a panel of health experts has added cervical cancer to the mix. Even though many doctors test for human papillomavirus, or HPV, as part of the routine women’s exams they provide, the U.

5 Things You Need to Know About Cervical Cancer

In the case of cervical cancer, there is good news. Over the past 40 years, the mortality rate for cervical cancer patients has decreased by over 50 percent, thanks to the increased prevalence of the Pap test. The even better news is that in many cases, cervical cancer can be avoided altogether.

Reduce your risk of cervical cancer: get screened for HPV

Get screened for HPV. That’s the message from experts working to reduce the number of cervical cancer cases.

HPV test makes cervical cancer screening easier for most women

The U.S. Preventive Services Task Force released new guidelines for cervical cancer screening that may make it easier for more women to keep on top of their health. Instead of getting a Pap smear every year, many women may be able to go three years — and sometimes up to five years — between cervical cancer screenings.

ASCO 2013: Vinegar for cervical cancer screening (VIDEOS)

The American Society of Clinical Oncology (ASCO) annual meeting in Chicago, May 31 through June 4, showcased two landmark studies about cervical cancer. One analyzed the effectiveness of a low-cost screening method in developing countries; the other found that the drug Avastin may benefit women with advanced disease.

Cervical cancer study suggests extended screening might be necessary

Rates of cervical cancer in the United States have been greatly underestimated, especially among women in their 60s and black women, according to a new study in the journal Cancer . A new study found that the rates of cervical cancer have been greatly underestimated.

Low Vaccination Rates for HPV a Serious ‘Public Health Threat’

Several types of high-risk HPV are responsible for the vast majority of cervical, anal, oropharyngeal (middle throat) and other genital cancers that affect men and women. Although many of these HPV-associated cancers are preventable with a safe and effective vaccine, HPV vaccination (HPVV) rates across the U.S. remain low.